Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 40 | ESEBEC2016 | Next issue

ESE Basic Endocrinology Course on Endocrine and Neuroendocrine Cancer 2016

ESE Basic Course on Endocrine and Neuroendocrine Cancer 2016

AIP and the somatostatin signalling in pituitary tumours

ea0040l16 | AIP and the somatostatin signalling in pituitary tumours | ESEBEC2016

AIP and the somatostatin signalling in pituitary tumours

Korbonits Marta

Germline mutations in the AIP gene predispose to the development of pituitary adenomas, most often GH secreting tumours. These patients often poorly respond to medical therapy with somatostatin analogues.There are two mechanisms suggested to be involved in this poor response.One suggests that the somatostatin-induced upregulation of the tumour suppressor gene Zac1 involves AIP. SSTR2 agonist treatment leads to AIP...

ea0040lb16 | AIP and the somatostatin signalling in pituitary tumours | ESEBEC2016

L16 – Biography

Prof. Márta Korbonits, MD, PhD, DSc, FRCP, is a clinical academic endocrinologist. She graduated in medicine at Semmelweis Medical School in Budapest and works in the Department of Endocrinology at Barts and the London School of Medicine, where she is Co-Centre Head. She shares her time between clinical patient care, clinical research and laboratory-based research as well as teaching at undergraduate and postgrad...